What preoperative recommendations should be followed for a hypothyroid patient on desiccated pork thyroid (thyroid extract) undergoing a major surgery with an anticipated NPO period of more than 12 hours?

Preoperative Management of Desiccated Thyroid (Pork Thyroid Extract) in Hypothyroid Patients

Continue desiccated thyroid extract on the morning of surgery at 75-80% of the usual dose, or give the full dose if the NPO period will be brief, and monitor closely for signs of hypothyroidism during the perioperative period.

Key Perioperative Principles

The management of hypothyroid patients on desiccated thyroid extract (DTE) undergoing surgery requires careful attention to maintaining thyroid hormone levels during the NPO period. While specific guidelines for DTE are limited, the principles established for levothyroxine replacement apply, with important considerations for DTE's unique pharmacokinetics.

Preoperative Assessment and Optimization

• Verify euthyroid status before elective surgery by measuring TSH levels as part of preoperative evaluation 1, 2
• Postpone elective procedures if the patient has uncontrolled hypothyroidism 3
• Exception: In patients with coronary artery disease requiring revascularization, address coronary blood flow first before optimizing thyroid replacement 1

The evidence strongly supports achieving biochemical euthyroidism before surgery when possible, as overt hypothyroidism is associated with impaired wound healing, prolonged ventilation, cardiovascular complications, and increased perioperative morbidity 1, 2.

Day of Surgery Management

Based on perioperative diabetes and endocrine guidelines that address thyroid replacement 4, 5, 6:

Morning of Surgery Protocol:

• Give 75-80% of the usual DTE dose on the morning of surgery 4, 5, 6
• Alternatively, give half the dose if using a more conservative approach 5
• Administer with a small sip of water even during NPO status

Rationale: DTE contains both T4 (levothyroxine) and T3 (liothyronine). The T4 component has a long half-life (7 days), providing a buffer against acute deficiency. However, the T3 component has a much shorter half-life (1 day), making complete omission potentially problematic during prolonged NPO periods 7.

Intraoperative Considerations

• Monitor blood glucose if the patient has concurrent diabetes, as thyroid hormone affects insulin requirements 7
• Maintain hemodynamic stability, as hypothyroid patients may have:
  • Decreased cardiac output
  • Impaired response to vasopressors
  • Increased sensitivity to anesthetics 1, 8

Postoperative Management

Resume oral DTE as soon as oral intake is tolerated:

• Return to the usual preoperative dose once the patient can take oral medications
• If prolonged NPO status is anticipated (>24-48 hours), consider alternative strategies

For Extended NPO Periods:

If oral intake will be delayed beyond 48 hours, you have several options:

1. Nasogastric tube administration: DTE can be crushed and administered via NG tube 7

2. Temporary IV levothyroxine: Though not ideal since it doesn't replace the T3 component of DTE

   • Calculate approximate T4 equivalent (DTE 60mg ≈ levothyroxine 100mcg)
   • Give 75-80% of calculated dose IV daily 7

3. Monitor for clinical hypothyroidism: Watch for bradycardia, hypotension, hypothermia, delayed awakening from anesthesia 1, 8

Critical Monitoring Parameters

Watch for signs of perioperative hypothyroidism:

• Cardiovascular: Bradycardia, hypotension, decreased cardiac output
• Respiratory: Hypoventilation, prolonged mechanical ventilation
• Metabolic: Hypothermia, hyponatremia
• Neurologic: Delayed emergence from anesthesia, altered mental status 1, 8, 9

Laboratory monitoring:

• Check TSH and free T4 levels 6-8 weeks postoperatively to ensure adequate replacement 10
• Earlier testing if clinical signs of hypothyroidism develop

Important Drug Interactions During Perioperative Period

Be aware that DTE absorption and effectiveness can be affected by 7:

• Cholestyramine/colestipol: Separate by 4-5 hours if used
• Oral anticoagulants: Thyroid hormone increases catabolism of vitamin K-dependent clotting factors; monitor PT/INR closely
• Insulin/oral hypoglycemics: May need dose adjustments as thyroid status affects glucose metabolism
• Biotin supplements: Stop at least 2 days before thyroid function testing 7

Special Considerations for DTE vs. Levothyroxine

DTE differs from synthetic levothyroxine in several clinically relevant ways:

• Contains both T4 and T3 in a fixed ratio (approximately 4:1)
• T3 component has shorter half-life, requiring more attention to missed doses
• Less standardized than synthetic preparations
• Patient preference often drives DTE use, with increasing utilization (doubled from 2010-2020) 11

Common Pitfalls to Avoid

1. Do not completely withhold thyroid hormone on the day of surgery—the long half-life of T4 provides some buffer, but the T3 component requires more frequent dosing
2. Do not confuse hypothyroidism with euthyroid sick syndrome in the postoperative period—low T3/T4 with normal/low TSH in critically ill patients does not require treatment 1
3. Do not delay urgent/emergent surgery to optimize thyroid function—proceed with surgery and manage thyroid status perioperatively 2
4. Do not assume IV levothyroxine alone adequately replaces DTE—it lacks the T3 component that some patients may depend on

Algorithm for Decision-Making

For elective surgery:

1. Check TSH preoperatively → If abnormal, optimize before surgery
2. Give 75-80% of usual DTE dose morning of surgery
3. Resume full dose when oral intake tolerated
4. If NPO >48 hours, use NG tube or consider IV T4 supplementation

For urgent/emergent surgery:

1. Proceed with surgery regardless of thyroid status
2. Give partial DTE dose if time permits
3. Monitor closely for cardiovascular/respiratory complications
4. Resume oral therapy as soon as feasible postoperatively

This approach balances the need to maintain thyroid hormone levels with the practical constraints of perioperative care, prioritizing patient safety and optimal surgical outcomes.